| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6184725 | Gynecologic Oncology | 2016 | 6 Pages |
Abstract
Referral of RM uLMS patients by GYN/ONC to a dedicated clinical trials-based SC resulted in an increase in the number of chemotherapy regimens prescribed and clinical trial enrollments. Partnership between GYN/ONC and a dedicated SC with access to clinical trials should be encouraged for all RM uLMS patients.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
S.E.S. Lange, J. Liu, D.R. Adkins, M.A. Powell, B.A. Van Tine, D.G. Mutch,